News tagged with clopidogrel
Study contradicts reports of problems with blood-thinner
New findings by McMaster University researchers contradict earlier reports that people with a certain genetic make-up don't benefit from the blood-thinner clopidogrel, also known as Plavix.
Medicine & Health / Medications
Aug 29, 2010 |
not rated yet |
0
Genetic variations linked with worse outcomes with use of antiplatelet drug for cardiac procedures
An analysis of data from previously published studies indicates that use of the antiplatelet drug clopidogrel for patients who have common genetic variants of a certain gene and are undergoing a procedure such as coronary ...
Medicine & Health / Medical research
Oct 26, 2010 |
not rated yet |
0
Breakthrough in drug trial offers hope for heart attack patients
New findings from a major drug trial have brought experts a step closer to developing a drug which could prevent thousands of British deaths from heart attacks.
Medicine & Health / Medical research
Sep 13, 2010 |
not rated yet |
0
Plavix may be treatment for dogs at risk of thromboembolic disease
Companion animals that have a long-term need for anticoagulant drug therapies may soon find help in a top-selling antiplatelet drug marketed to humans: clopidogrel, commonly known by the trade-name Plavix.
Jul 14, 2010 |
not rated yet |
0
Drug ads ineffective for boosting sales, could cost taxpayers: study
US Taxpayers may be on the hook for the high cost of drug advertising that does little to boost sales, according to a new study led by a University of British Columbia health policy researcher.
Nov 23, 2009 |
not rated yet |
0
How life-threatening blood clots take hold
When plaques coating blood vessel walls rupture and expose collagen, platelets spring into action to form a blood clot at the damaged site. Now, a new report in the April 17th issue of the journal Cell, a Cell Press public ...
Medicine & Health / Medical research
Apr 16, 2009 |
not rated yet |
0
Aspirin use associated with lower risk of cancer death for men with prostate cancer
Men with prostate cancer who take anticoagulants like aspirin in addition to radiation therapy or surgery may be able to cut their risk of dying of the disease by more than half, according to a large study presented on November ...
Oct 25, 2010 |
5 / 5 (2) |
0
Genetic variation in key cell pumping mechanism reduces effects of clopidogrel treatment
A study published Online First and in an upcoming Lancet shows that patients with a genetic variation affecting a key protein pump in drug transport do not respond as well to the anticlotting drug clopidogrel—as such, patien ...
Medicine & Health / Medical research
Aug 29, 2010 |
not rated yet |
0
Ticagrelor is better than clopidogrel to prevent blood clots regardless of genetic profile
A study published Online First and in an upcoming Lancet shows that anticlotting treatment using ticagrelor is better than clopidogrel, regardless of the presence of genetic variations that leads to variable efficacy of clo ...
Medicine & Health / Medical research
Aug 29, 2010 |
not rated yet |
0
Treating metabolic syndrome, undergoing carotid angioplasty
Treating metabolic syndrome and undergoing carotid angioplasty may prevent recurrent stroke or transient ischemic attack (TIA), according to revised American Heart Association/American Stroke Association guidelines.
Medicine & Health / Diseases, Conditions, Syndromes
Oct 21, 2010 |
not rated yet |
0
Study examines use of stent with bioabsorbable polymer
Three-year data demonstrated that satisfactory clinical and safety outcomes of sirolimus eluting stents with a biodegradable polymer were sustained in a real world setting. The results were presented at the 22nd annual Transcatheter ...
Medicine & Health / Medical research
Sep 21, 2010 |
not rated yet |
0
Cogent trial shows lack of adverse interaction between clopidogrel and stomach medicine
Results from a late breaking clinical trial called COGENT demonstrate that the combination of giving patients clopidogrel, a blood thinner commonly prescribed to patients with cardiovascular disease, and stomach medicines ...
Medicine & Health / Medical research
Sep 24, 2009 |
not rated yet |
0
Genetic variation associated with poorer response, cardiovascular outcomes with use of clopidogrel
Patients with a certain genetic variation who received the antiplatelet drug clopidogrel had a decreased platelet response to treatment and among those who had percutaneous coronary intervention (procedures such as balloon ...
Medicine & Health / Medical research
Aug 25, 2009 |
not rated yet |
0
Platelet function tests may provide modest benefit in predicting cardiac outcomes
An analysis of six tests that are used to measure platelet function and help gauge the effectiveness of antiplatelet drugs for patients undergoing a cardiac procedure such as a coronary stent implantation found that only ...
Medicine & Health / Medical research
Feb 23, 2010 |
not rated yet |
0
First study examines postpolypectomy bleeding in colonoscopy patients on uninterrupted clopidogrel
Researchers at the Syracuse Veterans Affairs Medical Center in New York examined postpolypectomy bleeding in patients undergoing colonoscopy on uninterrupted clopidogrel and found that the postpolypectomy bleeding rate is ...
Medicine & Health / Medical research
May 19, 2010 |
not rated yet |
0
Clopidogrel
Clopidogrel is an oral, thienopyridine class antiplatelet agent used to inhibit blood clots in coronary artery disease, peripheral vascular disease, and cerebrovascular disease. It is marketed by Bristol-Myers Squibb and Sanofi-Aventis under the trade name Plavix. The drug works by irreversibly inhibiting a receptor called P2Y12, an adenosine diphosphate ADP chemoreceptor. Adverse effects include hemorrhage, severe neutropenia, and thrombotic thrombocytopenic purpura (TTP).
For more information about Clopidogrel, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.
